Literature DB >> 15028075

Gender difference and drug challenge in Brugada syndrome.

Wataru Shimizu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15028075     DOI： 10.1046/j.1540-8167.2004.03557.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN： 1045-3873


× No keyword cloud information.
  4 in total

Review 1.  Is there an overlap between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia?

Authors:  Andrés Ricardo Pérez Riera; Charles Antzelevitch; Edgardo Schapacknik; Sergio Dubner; Celso Ferreira
Journal:  J Electrocardiol       Date:  2005-07       Impact factor: 1.438

2.  Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome.

Authors:  Kate S Stokoe; Richard Balasubramaniam; Catharine A Goddard; William H Colledge; Andrew A Grace; Christopher L-H Huang
Journal:  J Physiol       Date:  2007-02-15       Impact factor: 5.182

3.  Delayed conduction and its implications in murine Scn5a(+/-) hearts: independent and interacting effects of genotype, age, and sex.

Authors:  Kamalan Jeevaratnam; Sui Poh Tee; Yanmin Zhang; Rebecca Rewbury; Laila Guzadhur; Rudolf Duehmke; Andrew A Grace; Ming Lei; Christopher L-H Huang
Journal:  Pflugers Arch       Date:  2010-12-03       Impact factor: 3.657

4.  Lack of Influence of the Androgen Receptor Gene CAG-Repeat Polymorphism on Clinical and Electrocardiographic Manifestations of the Brugada Syndrome in Man.

Authors:  S Mariani; B Musumeci; S Basciani; D Fiore; P Francia; A Persichetti; M Volpe; C Autore; C Moretti; S Ulisse; L Gnessi
Journal:  Clin Med Insights Cardiol       Date:  2012-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.